Works matching DE "TREATMENT of chronic myeloid leukemia"

Results: 752

Chronic myelogenous leukemia. Curable with early diagnosis and treatment.

Published in:

1999

By:

Hill, J M;
Meehan, K R

Publication type:

journal article

A Simple Electrochemical Aptamer Cytosensor for Direct Detection of Chronic Myelogenous Leukemia K562 Cells.

Published in:

Electroanalysis, 2017, v. 29, n. 3, p. 828, doi. 10.1002/elan.201600505

By:

Yu, Tianxiao;
Zhang, Hui;
Huang, Zhenglan;
Luo, Zhenhong;
Huang, Ningshu;
Ding, Shijia;
Feng, Wenli

Publication type:

Article

Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia.

Published in:

Oncologist, 2021, v. 26, n. 5, p. 406, doi. 10.1002/onco.13769

By:

Tremblay, Douglas;
Rippel, Noa;
Feld, Jonathan;
El Jamal, Siraj M.;
Mascarenhas, John

Publication type:

Article

Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, p. S208, doi. 10.1080/21691401.2018.1490310

By:

Ma, Dan;
Wang, Ping;
Fang, Qin;
Yu, Zhengyu;
Zhou, Zhen;
He, Zhengchang;
Wei, Danna;
Yu, Kunling;
Lu, Tingting;
Zhang, Yaming;
Wang, Jishi

Publication type:

Article

Absolute Bioavailability of Bosutinib in Healthy Subjects From an Open‐Label, Randomized, 2‐Period Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 4, p. 373, doi. 10.1002/cpdd.396

By:

Hsyu, Poe‐Hirr;
Pignataro, Daniela Soriano;
Matschke, Kyle

Publication type:

Article

Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia With Losing Major Molecular Response as a Definition for Molecular Relapse: A Systematic Review and Meta-Analysis.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00372

By:

Chen, Kang-kang;
Du, Tai-feng;
Xiong, Pei-sheng;
Fan, Guan-hua;
Yang, Wei

Publication type:

Article

Residual Peripheral Blood CD26<sup>+</sup> Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission.

Published in:

Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00194

By:

Bocchia, Monica;
Sicuranza, Anna;
Abruzzese, Elisabetta;
Iurlo, Alessandra;
Sirianni, Santina;
Gozzini, Antonella;
Galimberti, Sara;
Aprile, Lara;
Martino, Bruno;
Pregno, Patrizia;
Sorà, Federica;
Alunni, Giulia;
Fava, Carmen;
Castagnetti, Fausto;
Puccetti, Luca;
Breccia, Massimo;
Cattaneo, Daniele;
Defina, Marzia;
Mulas, Olga;
Baratè, Claudia

Publication type:

Article

Development of myasthenia gravis in a patient with chronic myeloid leukemia during treatment with nilotinib.

Published in:

2014

By:

Sanford, David;
MacDonald, Maria;
Nicolle, Michael;
Xenocostas, Anargyros

Publication type:

Case Study

Treatments for chronic myeloid leukemia: a qualitative systematic review.

Published in:

Journal of Blood Medicine, 2012, v. 3, p. 51, doi. 10.2147/JBM.S33380

By:

Ferdinand, Roxanne;
Mitchell, Stephen A.;
Batson, Sarah;
Tumur, Indra

Publication type:

Article

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy.

Published in:

Case Reports in Cardiology, 2018, p. 1, doi. 10.1155/2018/3895197

By:

Nishimori, Makoto;
Honjo, Tomoyuki;
Kaihotsu, Kenji;
Sone, Naohiko;
Yoshikawa, Sachiko;
Imanishi, Junichi;
Nakayama, Kazuhiko;
Emoto, Noriaki;
Iwahashi, Masanori

Publication type:

Article

Radotinib-induced lentiginosis: a report of an adverse cutaneous reaction associated with a tyrosine kinase inhibitor.

Published in:

Clinical & Experimental Dermatology, 2016, v. 41, n. 2, p. 162, doi. 10.1111/ced.12706

By:

Won, K. H.;
Jo, S. Y.;
Lee, Y. J.;
Chang, S. E.

Publication type:

Article

Multiple squamous cell carcinomas following introduction of nilotinib.

Published in:

Clinical & Experimental Dermatology, 2014, v. 39, n. 7, p. 791, doi. 10.1111/ced.12388

By:

Peters, P.;
Rabbolini, D.;
Sinnya, S.;
Khosrotehrani, K.;
Wagner, G.

Publication type:

Article

Semi-random mutagenesis profile of BCR-ABL during imatinib resistance acquirement in K562 cells.

Published in:

Molecular Medicine Reports, 2017, v. 16, n. 6, p. 9409, doi. 10.3892/mmr.2017.7835

By:

YAN DONG;
XIAOTONG GAO;
YINGXIN ZHAO;
MENGYING WEI;
LINGMIN XU;
GUODONG YANG;
LI LIU

Publication type:

Article

Investigating critical genes and gene interaction networks that mediate cyclophosphamide sensitivity in chronic myelogenous leukemia.

Published in:

Molecular Medicine Reports, 2017, v. 16, n. 1, p. 523, doi. 10.3892/mmr.2017.6636

By:

Xiao He;
Yuying Deng;
Wei Yue

Publication type:

Article

Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering.

Published in:

Nature Chemistry, 2014, v. 6, n. 7, p. 614, doi. 10.1038/nchem.1961

By:

Fu, Dan;
Zhou, Jing;
Zhu, Wenjing Suzanne;
Manley, Paul W.;
Wang, Y. Karen;
Hood, Tami;
Wylie, Andrew;
Xie, X. Sunney

Publication type:

Article

Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA Registry.

Published in:

European Journal of Haematology, 2011, v. 87, n. 2, p. 157, doi. 10.1111/j.1600-0609.2011.01637.x

By:

Faber, Edgar;
Mužík, Jan;
Koza, Vladimír;
Demečková, Eva;
Voglová, Jaroslava;
Demitrovičová, Ĺudmila;
Chudej, Juraj;
Markuljak, Imrich;
Cmunt, Eduard;
Kozák, Tomáš;
Tóthová, Elena;
Jarošová, Marie;
Dušek, Ladislav;
Indrák, Karel

Publication type:

Article

Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib Olsson-Strömberg et al. Monitoring dasatinib treated patients.

Published in:

European Journal of Haematology, 2010, v. 85, n. 5, p. 399, doi. 10.1111/j.1600-0609.2010.01506.x

By:

Olsson-Strömberg, Ulla;
Hermansson, Monica;
Lundán, Tuija;
Ohm, Anne-Charlotte;
Engdahl, Ida;
Höglund, Martin;
Simonsson, Bengt;
Porkka, Kimmo;
Barbany, Gisela

Publication type:

Article

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib.

Published in:

Journal of Hematology & Oncology, 2010, v. 3, p. 47, doi. 10.1186/1756-8722-3-47

By:

Guoqing Wei;
Rafiyath, Shamudheen;
Delong Liu

Publication type:

Article

Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response.

Published in:

Biochemical Genetics, 2018, v. 56, n. 3, p. 149, doi. 10.1007/s10528-018-9841-1

By:

Behzad, Masumeh Maleki;
Shahrabi, Saeid;
Jaseb, Kaveh;
Bertacchini, Jessika;
Ketabchi, Neda;
Saki, Najmaldin

Publication type:

Article

Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling

Published in:

Molecular Oncology, 2012, v. 6, n. 3, p. 276, doi. 10.1016/j.molonc.2012.02.002

By:

Nam, Sangkil;
Scuto, Anna;
Yang, Fan;
Chen, WenYong;
Park, Sungman;
Yoo, Hwa-Seung;
Konig, Heiko;
Bhatia, Ravi;
Cheng, Xinlai;
Merz, Karl-Heinz;
Eisenbrand, Gerhard;
Jove, Richard

Publication type:

Article

Targeted Therapies: The Rare Cancer Paradigm

Published in:

Molecular Oncology, 2010, v. 4, n. 1, p. 19, doi. 10.1016/j.molonc.2009.10.003

By:

Pierotti, Marco A.;
Negri, Tiziana;
Tamborini, Elena;
Perrone, Federica;
Pricl, Sabrina;
Pilotti, Silvana

Publication type:

Article

The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia

Published in:

Molecular Oncology, 2008, v. 2, n. 3, p. 272, doi. 10.1016/j.molonc.2008.07.003

By:

Hantschel, Oliver;
Gstoettenbauer, Agnes;
Colinge, Jacques;
Kaupe, Ines;
Bilban, Martin;
Burkard, Thomas R.;
Valent, Peter;
Superti-Furga, Giulio

Publication type:

Article

Therapeutic leukocyte reduction for acute and chronic myeloid leukemias: A 4-year experience from an oncology center in India.

Published in:

Asian Journal of Transfusion Science, 2017, v. 11, n. 2, p. 156, doi. 10.4103/ajts.AJTS_103_16

By:

Tendulkar, Anita A.;
Jain, Puneet A.;
Gupta, Abhaykumar;
Sharma, Nidhi;
Navkudkar, Anisha;
Patle, Vijaya

Publication type:

Article

Autoimmune-Like Hepatitis.

Published in:

2016

By:

Baniak, Nick M.;
Kanthan, Rani

Publication type:

Case Study

Dasatinib (Sprycel) and pulmonary arterial hypertension.

Published in:: Australian Prescriber, 2012, v. 35, n. 2, p. 68
Publication type:: Article

Cell-penetrating fusion peptides OD1 and OD2 interact with Bcr–Abl and influence the growth and apoptosis of K562 cells.

Published in:

Molecular & Cellular Biochemistry, 2014, v. 385, n. 1/2, p. 311, doi. 10.1007/s11010-013-1841-1

By:

Wang, Hai-xia;
Xiao, Heng;
Zhong, Liang;
Tao, Kun;
Li, Ya-juan;
Huang, Shi-feng;
Wen, Jian-ping;
Feng, Wen-li

Publication type:

Article

A proteomic investigation into adriamycin chemo-resistance of human leukemia K562 cells.

Published in:

Molecular & Cellular Biochemistry, 2011, v. 351, n. 1/2, p. 233, doi. 10.1007/s11010-011-0730-8

By:

Xingchen Peng;
Fengming Gong;
Gang Xie;
Yuwei Zhao;
Minghai Tang;
Luoting Yu;
Aiping Tong

Publication type:

Article

Adherence to TKI in CML patients: more than reports.

Published in:

2018

By:

Souza, Jessica de O.;
Busato, Fernanda de O.;
Frota, Isadora Duarte Santos;
Neves, Daniel Santos;
de Deus Santos, Marcelo Renan;
Olivieri, David N.;
Tadokoro, Carlos E.

Publication type:

Letter

How to report adherence to treatment as clinically relevant data-making a case of CML and TKI.

Published in:

2018

By:

Okumura, Lucas Miyake

Publication type:

Letter

The role of clinical pharmacists in treatment adherence: fast impact in suppression of chronic myeloid leukemia development and symptoms.

Published in:

2017

By:

Moulin, Silmara;
Eutrópio, Frederico;
Souza, Jessica;
Busato, Fernanda;
Olivieri, David;
Tadokoro, Carlos;
Moulin, Silmara Mendes Martins;
Eutrópio, Frederico Jacob;
Souza, Jessica de Oliveira;
Busato, Fernanda de Oliveira;
Olivieri, David N;
Tadokoro, Carlos Eduardo

Publication type:

journal article

Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis.

Published in:

2016

By:

Breccia, Massimo;
Graffigna, Guendalina;
Galimberti, Sara;
Iurlo, Alessandra;
Pungolino, Ester;
Pizzuti, Michele;
Maggi, Alessandro;
Falzetti, Franca;
Capalbo, Silvana;
Intermesoli, Tamara;
Maffioli, Margherita;
Elena, Chiara;
Melosi, Alessandro;
Simonetti, Federico;
Capochiani, Enrico;
Seta, Roberta;
Pacilli, Matteo;
Luppi, Mario;
Di Renzo, Nicola;
Mastrullo, Lucia

Publication type:

journal article

CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity.

Published in:

European Journal of Clinical Pharmacology, 2010, v. 66, n. 4, p. 383, doi. 10.1007/s00228-009-0772-y

By:

Gréen, Henrik;
Skoglund, Karin;
Rommel, Franz;
Mirghani, Rajaa;
Lotfi, Kourosh

Publication type:

Article

Drug monitoring of imatinib levels in patients undergoing therapy for chronic myeloid leukaemia: comparing plasma levels of responders and non-responders.

Published in:

European Journal of Clinical Pharmacology, 2009, v. 65, n. 6, p. 545, doi. 10.1007/s00228-009-0621-z

By:

Singh, N.;
Kumar, L.;
Meena, R.;
Velpandian, T.

Publication type:

Article

Stevens-Johnson Syndrome Induced by Combination of Imatinib and Allopurinol.

Published in:

Chemotherapy (0009-3157), 2009, v. 55, n. 4, p. 197, doi. 10.1159/000218097

By:

Huei-Jen Hsieh;
Chan, Agnes L. F.;
Shun-Jen Lin

Publication type:

Article

Design of polyethylene glycol-polyethylenimine nanocomplexes as non-viral carriers: mir-150 delivery to chronic myeloid leukemia cells.

Published in:

Cell Biology International, 2013, v. 37, n. 11, p. 1205, doi. 10.1002/cbin.10157

By:

Biray Avcı, Çığır;
Özcan, İpek;
Balcı, Tuğçe;
Özer, Özgen;
Gündüz, Cumhur

Publication type:

Article

Antiproliferative, apoptotic and antioxidant activities of wheatgrass (Triticum aestivum L.) extract on CML (K562) cell line.

Published in:

Turkish Journal of Medical Sciences, 2011, v. 41, n. 4, p. 657, doi. 10.3906/sag-0912-425

By:

AYDOS, Oya Sena;
AVCI, Aslıhan;
ÖZKAN, Tülin;
KARADAĞ, Aynur;
GÜRLEYİK, Ebru;
ALTINOK, Buket;
SUNGUROĞLU, Asuman

Publication type:

Article

Why Doesn't Imatinib Cure Chronic Myeloid Leukemia?

Published in:

Oncologist, 2010, v. 15, n. 2, p. 182, doi. 10.1634/theoncologist.2009-0297

By:

Redner, Robert I.

Publication type:

Article

Identification of new molecular markers for response or relapse prediction in chronic myeloid leukemia, in patients treated with tyrosine-kinase inhibitors.

Published in:

Oncolog-Hematolog, 2015, n. 33, p. 47

By:

Crişan, Ana Manuela

Publication type:

Article

Permanent Bilateral Sensorineural Hearing Loss in a Patient Treated with Nilotinib for Chronic Myeloid Leukemia: A Case Report.

Published in:

Journal of Pioneering Medical Sciences, 2016, v. 6, n. 4, p. 107

By:

Saleem, Ayesha

Publication type:

Article

Biomarker Development and Validation Crucial to Use of Emerging Treatments in Solid Tumors and Hematologic Malignancies.

Published in:

2013

By:

Coleman, Rob;
Cortes, Jorge

Publication type:

Proceeding

Association between the concentration of imatinib in bone marrow mononuclear cells, mutation status of ABCB1 and therapeutic response in patients with chronic myelogenous leukemia.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 11, n. 5, p. 2061, doi. 10.3892/etm.2016.3127

By:

CHANG-XIN YIN;
WEI-WEI CHEN;
QING-XIU ZHONG;
XUE-JIE JIANG;
ZHI-XIANG WANG;
XIAO-DONG LI;
JIE-YU YE;
RUI CAO;
LI-BING LIAO;
FU-QUN WU;
DAN XU;
JIAN-SHENG ZHONG;
FAN-YI MENG

Publication type:

Article

Extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: A case report of successful diagnosis and treatment.

Published in:

Experimental & Therapeutic Medicine, 2015, v. 9, n. 3, p. 850, doi. 10.3892/etm.2015.2173

By:

DONG-FENG ZENG;
CHENG CHANG;
JIE-PING LI;
PEI-YAN KONG;
XI ZHANG;
LEI GAO

Publication type:

Article

Determination of a radotinib dosage regimen based on dose–response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia.

Published in:

Cancer Medicine, 2018, v. 7, n. 5, p. 1766, doi. 10.1002/cam4.1436

By:

Noh, Hayeon;
Jung, Su Young;
Kwak, Jae‐Yong;
Kim, Sung‐Hyun;
Oh, Suk Joong;
Zang, Dae Young;
Lee, Suhyun;
Park, Hye Lin;
Jo, Dae Jin;
Shin, Jae Soo;
Do, Young Rok;
Kim, Dong‐Wook;
Lee, Jangik I.

Publication type:

Article

Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?

Published in:

Cancer Medicine, 2018, v. 7, n. 2, p. 317, doi. 10.1002/cam4.1286

By:

Zhuang, Wei;
Xie, Jing‐Dun;
Zhou, Shan;
Zhou, Zhi‐Wei;
Zhou, Yi;
Sun, Xiao‐Wei;
Yuan, Xiu‐Hong;
Huang, Min;
Liu, Si;
Xin, Shuang;
Su, Qi‐Biao;
Qiu, Hai‐Bo;
Wang, Xue‐Ding

Publication type:

Article

Deep molecular responses for treatment-free remission in chronic myeloid leukemia.

Published in:

Cancer Medicine, 2016, v. 5, n. 9, p. 2398, doi. 10.1002/cam4.801

By:

Dulucq, Stéphanie;
Mahon, Francois‐Xavier

Publication type:

Article

Adjunctive Chinese Herbal Medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population-based cohort study.

Published in:

Cancer Medicine, 2016, v. 5, n. 4, p. 640, doi. 10.1002/cam4.627

By:

Fleischer, Tom;
Chang, Tung‐Ti;
Chiang, Jen‐Huai;
Chang, Ching‐Mao;
Hsieh, Ching‐Yun;
Yen, Hung‐Rong

Publication type:

Article

Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months.

Published in:

Cancer Medicine, 2015, v. 4, n. 7, p. 995, doi. 10.1002/cam4.440

By:

Casado, Luis‐Felipe;
García‐Gutiérrez, José‐Valentín;
Massagué, Isabel;
Giraldo, Pilar;
Pérez‐Encinas, Manuel;
Paz, Raquel;
Martínez‐López, Joaquín;
Bautista, Guiomar;
Osorio, Santiago;
Requena, María‐José;
Palomera, Luis;
Peñarrubia, María‐Jesús;
Calle, Carmen;
Hernández‐Rivas, José‐Ángel;
Burgaleta, Carmen;
Maestro, Begoña;
García‐Ormeña, Nuria;
Steegmann, Juan‐Luis

Publication type:

Article

TWO CASES OF CHRONIC MYELOID LEUKEMIA IN PEDIATRIC AND YOUNG ADOLESCENT AGE GROUP.

Published in:

Journal of Dhaka Medical College, 2016, v. 25, n. 1, p. 74

By:

M. Z., HOSSAIN;
P., HASAN;
B., AHMED;
K. T., MOZAZFIA;
Z., FERDUSH;
H., TASNIM;
M. A., KABIR;
M. S., KHAN

Publication type:

Article

Late Emergence of an Imatinib-Resistant ABL1 Kinase Domain Mutation in a Patient with Chronic Myeloid Leukemia.

Published in:

2017

By:

Crampe, Mireille;
Andrews, Claire;
Fortune, Anne;
Langabeer, Stephen E.

Publication type:

Case Study

Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemotherapy: Report of a Case.

Published in:

Case Reports in Hematology, 2017, p. 1, doi. 10.1155/2017/6167345

By:

Bucelli, Cristina;
Cattaneo, Daniele;
Ferla, Valeria;
Zappa, Manuela;
Benedittis, Caterina de;
Soverini, Simona;
Iurlo, Alessandra

Publication type:

Article